The Role of Direct Oral Anticoagulants in the Treatment of Cancer-Associated Venous Thromboembolism: Review by Middle East and North African Experts

S Bazarbashi, HM El Zawahry, T Owaidah… - Journal of Blood …, 2024 - Taylor & Francis
Venous thromboembolism is a leading cause of morbidity and mortality in patients with
active cancer who require anticoagulation treatment. Choice of anticoagulant is based on …

Cost‐Effectiveness and Budget Impact Analysis of Apixaban and Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Non‐Valvular Atrial …

A Tajik, A Abbasi, Z Goudarzi, A Izadi‐Moud… - Clinical …, 2024 - Wiley Online Library
Introduction This study evaluates the cost‐effectiveness of Apixaban and Rivaroxaban,
compared to Warfarin, for stroke prevention in patients with non‐valvular atrial fibrillation in …

Naoxintong Is Involved in the Coagulation Regulation of Warfarin Through the MAPK Pathway

X Luo, L Chen, J Xu, J Li - Pharmacogenomics and Personalized …, 2025 - Taylor & Francis
Objective To explore the effect of Naoxintong (NXT) on warfarin anticoagulation therapy and
its potential mechanism. Methods TCSMP, SwissTargetprediction, SuperPred, SEA, and …

[PDF][PDF] Anticoagulant and antithrombotic therapy: globally applied according to local geographical selection criteria

EJ Favaloro - Annals of Blood, 2020 - researchoutput.csu.edu.au
Antithrombotic therapy is applied to prevent or treat thrombosis in patients in a variety of
clinical settings (1-5). As overview, antithrombotic therapy comprises two main classes of …

[HTML][HTML] The Daily US News Updates

S Bazarbashi, HM El Zawahry, T Owaidah, MA AlBader… - thedailyusnews.com
Venous thromboembolism is a leading cause of morbidity and mortality in patients with
active cancer who require anticoagulation treatment. Choice of anticoagulant is based on …